ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Synthetic vs. Bioidentical Testosterone Therapy: TRT Treatment Guide Released

TRT Australia has released a new guide comparing the differences between bioidentical testosterone and synthetic testosterone, going over how each option can affect testosterone replacement therapy treatments.

-- TRT Australia has published a new guide, intended for men who are considering testosterone replacement therapy for low testosterone but are uncertain about the different types of testosterone medications. To help patients make informed decisions about their care, the resource explores the differences between bioidentical testosterone and synthetic testosterone and how they may impact treatment.

For more information, please visit https://trtaustralia.com/category/blog/

Testosterone, the primary male sex hormone, is responsible for many processes in the body, with chief functions in energy regulation, mental clarity, body composition, and sexual health. Testosterone production naturally decreases with age, but deficiencies can arise from medical conditions, injuries, or substance use, leading to symptoms like chronic fatigue, irritability, weight gain, and loss of lean muscle and bone mass. Because low testosterone can significantly impair quality of life, it is considered a medical condition and is often treated with testosterone replacement therapy (TRT).

In TRT, either synthetic or bioidentical testosterone is administered when patients present with symptoms and blood tests indicate that these drugs are medically appropriate. Most men who undergo treatment for low testosterone experience improved energy levels and moods, reduced body fat, and enhanced physical strength and cognitive function, regardless of the origin of the testosterone; however, experts like TRT Australia say that there are still some differences that prospective patients should be aware of.

Synthetic testosterone, which is made from altered forms of the base testosterone molecule, is often modified to be more bioavailable, making it an effective first line of treatment for men with testosterone deficiencies; bioidentical testosterone, which is derived from plant sources like soy and yam, is usually recommended when patients do not notice improvements to their symptoms or experience side effects from synthetic medications. The latter treatment is often customised to each patient, requiring guidance from a licensed provider who specialises in hormone imbalances to tailor doses to the patient’s specific needs.

As a licensed telehealth TRT clinic in Australia, TRT Australia can advise patients on which choice is best for them based on medical evaluations and personal preferences. Men suffering from low T can learn more by visiting https://trtaustralia.com/

Contact Info:
Name: James Malachowski
Email: Send Email
Organization: TRT Australia
Address: 7–11 The Avenue, Hurstville, NSW 2220, Australia
Website: https://trtaustralia.com/X

Source: PressCable

Release ID: 89186414

If there are any errors, inconsistencies, or queries arising from the content contained within this press release that require attention or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our reliable team will be available to promptly respond within 8 hours, taking proactive measures to rectify any identified issues or providing guidance on the removal process. Ensuring accurate and dependable information is our top priority.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.14
+4.77 (2.32%)
AAPL  251.49
+3.50 (1.41%)
AMD  202.68
+1.35 (0.67%)
BAC  47.52
+0.36 (0.76%)
GOOG  299.02
+0.23 (0.08%)
META  604.06
+10.40 (1.75%)
MSFT  383.00
+1.13 (0.30%)
NVDA  175.64
+2.94 (1.70%)
ORCL  154.34
+4.66 (3.11%)
TSLA  380.85
+12.89 (3.50%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.